Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “Path Planning”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,711 records · Page 95

MO-C-BRB-00: President’s Symposium: Revitalizing Scientific Excellence: Turning Research Into Clinical Reality Through Translational Research

Diagnostic radiology and radiation oncology are arguably two of the most technologically advanced specialties in medicine. The imaging and radiation medicine technologies in clinical use today have been continuously improved through new advances made in the commercial and academic research arenas. This symposium explores the translational path from research through clinical implementation. Dr. Pettigrew will start this discussion by sharing his perspectives as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB has focused on promoting research that is technological in nature and has high clinical impact. We are in the age of precision medicine, and the technological innovations and quantitative tools developed by engineers and physicists working with physicians are providing innovative tools that increase precision and improve outcomes in health care. NIBIB funded grants lead to a very high patenting rate (per grant dollar), and these patents have higher citation rates by other patents, suggesting greater clinical impact, as well. Two examples of clinical translation resulting from NIH-funded research will be presented, in radiation therapy and diagnostic imaging. Dr. Yu will describe a stereotactic radiotherapy device developed in his laboratory that is designed for treating breast cancer with the patient in the prone position. It uses 36 rotating Cobalt-60 sources positioned in an annular geometry to focus the radiation beam at the system’s isocenter. The radiation dose is delivered throughout the target volume in the breast by constantly moving the patient in a planned trajectory relative to the fixed isocenter. With this technique, the focal spot dynamically paints the dose distribution throughout the target volume in three dimensions. Dr. Jackson will conclude this symposium by describing the RSNA Quantitative Imaging Biomarkers Alliance (QIBA), which is funded in part by NIBIB and is a synergistic collaboration between medical physicists, radiologists, oncologists, industry representatives, and other stakeholders. The mission of QIBA is to improve the accuracy and practicality of quantitative image-based biomarkers by increasing precision across devices, patients, and time, an essential step in incorporating quantitative imaging biomarkers into radiology practice. Validated quantitative imaging biomarkers are necessary to support precision medicine initiatives, multimodality / multiparametric applications in medicine, treatment planning and response assessment, and radiogenomics applications. Current applications in the QIBA portfolio extend to cancer diagnosis and treatment, pulmonary diseases, and neurological disorders. The overall goal of this symposium is to illustrate the bidirectional exchange between medical research and clinical practice. Revitalizing scientific excellence in clinical medical physics challenges practitioners to identify clinical limitations, which then drive research innovation; research funded by the NIH and other agencies develops technological solutions to these limitations, which are translated to the care environment to ultimately improve clinical practice in radiology and radiation oncology.

60 APPLIED LIFE SCIENCES↗

MO-C-BRB-01: Introduction [ Diagnostic radiology and radiation oncology ]

Diagnostic radiology and radiation oncology are arguably two of the most technologically advanced specialties in medicine. The imaging and radiation medicine technologies in clinical use today have been continuously improved through new advances made in the commercial and academic research arenas. This symposium explores the translational path from research through clinical implementation. Dr. Pettigrew will start this discussion by sharing his perspectives as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB has focused on promoting research that is technological in nature and has high clinical impact. We are in the age of precision medicine, and the technological innovations and quantitative tools developed by engineers and physicists working with physicians are providing innovative tools that increase precision and improve outcomes in health care. NIBIB funded grants lead to a very high patenting rate (per grant dollar), and these patents have higher citation rates by other patents, suggesting greater clinical impact, as well. Two examples of clinical translation resulting from NIH-funded research will be presented, in radiation therapy and diagnostic imaging. Dr. Yu will describe a stereotactic radiotherapy device developed in his laboratory that is designed for treating breast cancer with the patient in the prone position. It uses 36 rotating Cobalt-60 sources positioned in an annular geometry to focus the radiation beam at the system’s isocenter. The radiation dose is delivered throughout the target volume in the breast by constantly moving the patient in a planned trajectory relative to the fixed isocenter. With this technique, the focal spot dynamically paints the dose distribution throughout the target volume in three dimensions. Dr. Jackson will conclude this symposium by describing the RSNA Quantitative Imaging Biomarkers Alliance (QIBA), which is funded in part by NIBIB and is a synergistic collaboration between medical physicists, radiologists, oncologists, industry representatives, and other stakeholders. The mission of QIBA is to improve the accuracy and practicality of quantitative image-based biomarkers by increasing precision across devices, patients, and time, an essential step in incorporating quantitative imaging biomarkers into radiology practice. Validated quantitative imaging biomarkers are necessary to support precision medicine initiatives, multimodality / multiparametric applications in medicine, treatment planning and response assessment, and radiogenomics applications. Current applications in the QIBA portfolio extend to cancer diagnosis and treatment, pulmonary diseases, and neurological disorders. The overall goal of this symposium is to illustrate the bidirectional exchange between medical research and clinical practice. Revitalizing scientific excellence in clinical medical physics challenges practitioners to identify clinical limitations, which then drive research innovation; research funded by the NIH and other agencies develops technological solutions to these limitations, which are translated to the care environment to ultimately improve clinical practice in radiology and radiation oncology.

60 APPLIED LIFE SCIENCES↗

MO-C-BRB-02: ASTRO President [ Diagnostic radiology and radiation oncology ]

Diagnostic radiology and radiation oncology are arguably two of the most technologically advanced specialties in medicine. The imaging and radiation medicine technologies in clinical use today have been continuously improved through new advances made in the commercial and academic research arenas. This symposium explores the translational path from research through clinical implementation. Dr. Pettigrew will start this discussion by sharing his perspectives as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB has focused on promoting research that is technological in nature and has high clinical impact. We are in the age of precision medicine, and the technological innovations and quantitative tools developed by engineers and physicists working with physicians are providing innovative tools that increase precision and improve outcomes in health care. NIBIB funded grants lead to a very high patenting rate (per grant dollar), and these patents have higher citation rates by other patents, suggesting greater clinical impact, as well. Two examples of clinical translation resulting from NIH-funded research will be presented, in radiation therapy and diagnostic imaging. Dr. Yu will describe a stereotactic radiotherapy device developed in his laboratory that is designed for treating breast cancer with the patient in the prone position. It uses 36 rotating Cobalt-60 sources positioned in an annular geometry to focus the radiation beam at the system’s isocenter. The radiation dose is delivered throughout the target volume in the breast by constantly moving the patient in a planned trajectory relative to the fixed isocenter. With this technique, the focal spot dynamically paints the dose distribution throughout the target volume in three dimensions. Dr. Jackson will conclude this symposium by describing the RSNA Quantitative Imaging Biomarkers Alliance (QIBA), which is funded in part by NIBIB and is a synergistic collaboration between medical physicists, radiologists, oncologists, industry representatives, and other stakeholders. The mission of QIBA is to improve the accuracy and practicality of quantitative image-based biomarkers by increasing precision across devices, patients, and time, an essential step in incorporating quantitative imaging biomarkers into radiology practice. Validated quantitative imaging biomarkers are necessary to support precision medicine initiatives, multimodality / multiparametric applications in medicine, treatment planning and response assessment, and radiogenomics applications. Current applications in the QIBA portfolio extend to cancer diagnosis and treatment, pulmonary diseases, and neurological disorders. The overall goal of this symposium is to illustrate the bidirectional exchange between medical research and clinical practice. Revitalizing scientific excellence in clinical medical physics challenges practitioners to identify clinical limitations, which then drive research innovation; research funded by the NIH and other agencies develops technological solutions to these limitations, which are translated to the care environment to ultimately improve clinical practice in radiology and radiation oncology.

60 APPLIED LIFE SCIENCES↗

MO-C-BRB-03: RSNA President [ Diagnostic radiology and radiation oncology ]

Diagnostic radiology and radiation oncology are arguably two of the most technologically advanced specialties in medicine. The imaging and radiation medicine technologies in clinical use today have been continuously improved through new advances made in the commercial and academic research arenas. This symposium explores the translational path from research through clinical implementation. Dr. Pettigrew will start this discussion by sharing his perspectives as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB has focused on promoting research that is technological in nature and has high clinical impact. We are in the age of precision medicine, and the technological innovations and quantitative tools developed by engineers and physicists working with physicians are providing innovative tools that increase precision and improve outcomes in health care. NIBIB funded grants lead to a very high patenting rate (per grant dollar), and these patents have higher citation rates by other patents, suggesting greater clinical impact, as well. Two examples of clinical translation resulting from NIH-funded research will be presented, in radiation therapy and diagnostic imaging. Dr. Yu will describe a stereotactic radiotherapy device developed in his laboratory that is designed for treating breast cancer with the patient in the prone position. It uses 36 rotating Cobalt-60 sources positioned in an annular geometry to focus the radiation beam at the system’s isocenter. The radiation dose is delivered throughout the target volume in the breast by constantly moving the patient in a planned trajectory relative to the fixed isocenter. With this technique, the focal spot dynamically paints the dose distribution throughout the target volume in three dimensions. Dr. Jackson will conclude this symposium by describing the RSNA Quantitative Imaging Biomarkers Alliance (QIBA), which is funded in part by NIBIB and is a synergistic collaboration between medical physicists, radiologists, oncologists, industry representatives, and other stakeholders. The mission of QIBA is to improve the accuracy and practicality of quantitative image-based biomarkers by increasing precision across devices, patients, and time, an essential step in incorporating quantitative imaging biomarkers into radiology practice. Validated quantitative imaging biomarkers are necessary to support precision medicine initiatives, multimodality / multiparametric applications in medicine, treatment planning and response assessment, and radiogenomics applications. Current applications in the QIBA portfolio extend to cancer diagnosis and treatment, pulmonary diseases, and neurological disorders. The overall goal of this symposium is to illustrate the bidirectional exchange between medical research and clinical practice. Revitalizing scientific excellence in clinical medical physics challenges practitioners to identify clinical limitations, which then drive research innovation; research funded by the NIH and other agencies develops technological solutions to these limitations, which are translated to the care environment to ultimately improve clinical practice in radiology and radiation oncology.

60 APPLIED LIFE SCIENCES↗

MO-C-BRB-04: The role of the NIH in funding innovations in science and medicine

Diagnostic radiology and radiation oncology are arguably two of the most technologically advanced specialties in medicine. The imaging and radiation medicine technologies in clinical use today have been continuously improved through new advances made in the commercial and academic research arenas. This symposium explores the translational path from research through clinical implementation. Dr. Pettigrew will start this discussion by sharing his perspectives as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB has focused on promoting research that is technological in nature and has high clinical impact. We are in the age of precision medicine, and the technological innovations and quantitative tools developed by engineers and physicists working with physicians are providing innovative tools that increase precision and improve outcomes in health care. NIBIB funded grants lead to a very high patenting rate (per grant dollar), and these patents have higher citation rates by other patents, suggesting greater clinical impact, as well. Two examples of clinical translation resulting from NIH-funded research will be presented, in radiation therapy and diagnostic imaging. Dr. Yu will describe a stereotactic radiotherapy device developed in his laboratory that is designed for treating breast cancer with the patient in the prone position. It uses 36 rotating Cobalt-60 sources positioned in an annular geometry to focus the radiation beam at the system’s isocenter. The radiation dose is delivered throughout the target volume in the breast by constantly moving the patient in a planned trajectory relative to the fixed isocenter. With this technique, the focal spot dynamically paints the dose distribution throughout the target volume in three dimensions. Dr. Jackson will conclude this symposium by describing the RSNA Quantitative Imaging Biomarkers Alliance (QIBA), which is funded in part by NIBIB and is a synergistic collaboration between medical physicists, radiologists, oncologists, industry representatives, and other stakeholders. The mission of QIBA is to improve the accuracy and practicality of quantitative image-based biomarkers by increasing precision across devices, patients, and time, an essential step in incorporating quantitative imaging biomarkers into radiology practice. Validated quantitative imaging biomarkers are necessary to support precision medicine initiatives, multimodality / multiparametric applications in medicine, treatment planning and response assessment, and radiogenomics applications. Current applications in the QIBA portfolio extend to cancer diagnosis and treatment, pulmonary diseases, and neurological disorders. The overall goal of this symposium is to illustrate the bidirectional exchange between medical research and clinical practice. Revitalizing scientific excellence in clinical medical physics challenges practitioners to identify clinical limitations, which then drive research innovation; research funded by the NIH and other agencies develops technological solutions to these limitations, which are translated to the care environment to ultimately improve clinical practice in radiology and radiation oncology.

60 APPLIED LIFE SCIENCES↗

MO-C-BRB-05: Translating NIH funding to a [potential] clinical device in breast cancer radiation therapy

Diagnostic radiology and radiation oncology are arguably two of the most technologically advanced specialties in medicine. The imaging and radiation medicine technologies in clinical use today have been continuously improved through new advances made in the commercial and academic research arenas. This symposium explores the translational path from research through clinical implementation. Dr. Pettigrew will start this discussion by sharing his perspectives as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB has focused on promoting research that is technological in nature and has high clinical impact. We are in the age of precision medicine, and the technological innovations and quantitative tools developed by engineers and physicists working with physicians are providing innovative tools that increase precision and improve outcomes in health care. NIBIB funded grants lead to a very high patenting rate (per grant dollar), and these patents have higher citation rates by other patents, suggesting greater clinical impact, as well. Two examples of clinical translation resulting from NIH-funded research will be presented, in radiation therapy and diagnostic imaging. Dr. Yu will describe a stereotactic radiotherapy device developed in his laboratory that is designed for treating breast cancer with the patient in the prone position. It uses 36 rotating Cobalt-60 sources positioned in an annular geometry to focus the radiation beam at the system’s isocenter. The radiation dose is delivered throughout the target volume in the breast by constantly moving the patient in a planned trajectory relative to the fixed isocenter. With this technique, the focal spot dynamically paints the dose distribution throughout the target volume in three dimensions. Dr. Jackson will conclude this symposium by describing the RSNA Quantitative Imaging Biomarkers Alliance (QIBA), which is funded in part by NIBIB and is a synergistic collaboration between medical physicists, radiologists, oncologists, industry representatives, and other stakeholders. The mission of QIBA is to improve the accuracy and practicality of quantitative image-based biomarkers by increasing precision across devices, patients, and time, an essential step in incorporating quantitative imaging biomarkers into radiology practice. Validated quantitative imaging biomarkers are necessary to support precision medicine initiatives, multimodality / multiparametric applications in medicine, treatment planning and response assessment, and radiogenomics applications. Current applications in the QIBA portfolio extend to cancer diagnosis and treatment, pulmonary diseases, and neurological disorders. The overall goal of this symposium is to illustrate the bidirectional exchange between medical research and clinical practice. Revitalizing scientific excellence in clinical medical physics challenges practitioners to identify clinical limitations, which then drive research innovation; research funded by the NIH and other agencies develops technological solutions to these limitations, which are translated to the care environment to ultimately improve clinical practice in radiology and radiation oncology.

60 APPLIED LIFE SCIENCES↗

MO-C-BRB-06: Translating NIH / NIBIB funding to clinical reality in quantitative diagnostic imaging

Diagnostic radiology and radiation oncology are arguably two of the most technologically advanced specialties in medicine. The imaging and radiation medicine technologies in clinical use today have been continuously improved through new advances made in the commercial and academic research arenas. This symposium explores the translational path from research through clinical implementation. Dr. Pettigrew will start this discussion by sharing his perspectives as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB has focused on promoting research that is technological in nature and has high clinical impact. We are in the age of precision medicine, and the technological innovations and quantitative tools developed by engineers and physicists working with physicians are providing innovative tools that increase precision and improve outcomes in health care. NIBIB funded grants lead to a very high patenting rate (per grant dollar), and these patents have higher citation rates by other patents, suggesting greater clinical impact, as well. Two examples of clinical translation resulting from NIH-funded research will be presented, in radiation therapy and diagnostic imaging. Dr. Yu will describe a stereotactic radiotherapy device developed in his laboratory that is designed for treating breast cancer with the patient in the prone position. It uses 36 rotating Cobalt-60 sources positioned in an annular geometry to focus the radiation beam at the system’s isocenter. The radiation dose is delivered throughout the target volume in the breast by constantly moving the patient in a planned trajectory relative to the fixed isocenter. With this technique, the focal spot dynamically paints the dose distribution throughout the target volume in three dimensions. Dr. Jackson will conclude this symposium by describing the RSNA Quantitative Imaging Biomarkers Alliance (QIBA), which is funded in part by NIBIB and is a synergistic collaboration between medical physicists, radiologists, oncologists, industry representatives, and other stakeholders. The mission of QIBA is to improve the accuracy and practicality of quantitative image-based biomarkers by increasing precision across devices, patients, and time, an essential step in incorporating quantitative imaging biomarkers into radiology practice. Validated quantitative imaging biomarkers are necessary to support precision medicine initiatives, multimodality / multiparametric applications in medicine, treatment planning and response assessment, and radiogenomics applications. Current applications in the QIBA portfolio extend to cancer diagnosis and treatment, pulmonary diseases, and neurological disorders. The overall goal of this symposium is to illustrate the bidirectional exchange between medical research and clinical practice. Revitalizing scientific excellence in clinical medical physics challenges practitioners to identify clinical limitations, which then drive research innovation; research funded by the NIH and other agencies develops technological solutions to these limitations, which are translated to the care environment to ultimately improve clinical practice in radiology and radiation oncology.

60 APPLIED LIFE SCIENCES↗

Laboratory Scoping Tests Of Decontamination Of Hanford Waste Treatment Plant Low Activity Waste Off-Gas Condensate Simulant

The Hanford Waste Treatment and Immobilization Plant (WTP) Low Activity Waste (LAW) vitrification facility will generate an aqueous condensate recycle stream (LAW Off-Gas Condensate) from the off-gas system. The baseline plan for disposition of this stream is to send it to the WTP Pretreatment Facility, where it will be blended with LAW, concentrated by evaporation and recycled to the LAW vitrification facility again. Alternate disposition of this stream would eliminate recycling of problematic components, and would enable de-coupled operation of the LAW melter and the Pretreatment Facilities. Eliminating this stream from recycling within WTP would also decrease the LAW vitrification mission duration and quantity of glass waste. This LAW Off-Gas Condensate stream contains components that are volatile at melter temperatures and are problematic for the glass waste form. Because this stream recycles within WTP, these components accumulate in the Condensate stream, exacerbating their impact on the number of LAW glass containers that must be produced. Approximately 32% of the sodium in Supplemental LAW comes from glass formers used to make the extra glass to dilute the halides to acceptable concentrations in the LAW glass, and diverting the stream reduces the halides in the recycled Condensate and is a key outcome of this work. Additionally, under possible scenarios where the LAW vitrification facility commences operation prior to the WTP Pretreatment facility, identifying a disposition path becomes vitally important. This task seeks to examine the potential treatment of this stream to remove radionuclides and subsequently disposition the decontaminated stream elsewhere, such as the Effluent Treatment Facility (ETF), for example. The treatment process envisioned is very similar to that used for the Actinide Removal Process (ARP) that has been operating for years at the Savannah River Site (SRS), and focuses on using mature radionuclide removal technologies that are also compatible with longterm tank storage and immobilization methods. For this new application, testing is needed to demonstrate acceptable treatment sorbents and precipitating agents and measure decontamination factors for additional radionuclides in this unique waste stream. The origin of this LAW Off-Gas Condensate stream will be the liquids from the Submerged Bed Scrubber (SBS) and the Wet Electrostatic Precipitator (WESP) from the LAW melter off-gas system. The stream is expected to be a dilute salt solution with near neutral pH, and will likely contain some insoluble solids from melter carryover. The soluble components are expected to be mostly sodium and ammonium salts of nitrate, chloride, and fluoride. This stream has not been generated yet and will not be available until the WTP begins operation, but a simulant has been produced based on models, calculations, and comparison with pilot-scale tests. One of the radionuclides that is volatile and expected to be in high concentration in this LAW Off-Gas Condensate stream is Technetium-99 ( 99 Tc). Technetium will not be removed from the aqueous waste in the Hanford WTP, and will primarily end up immobilized in the LAW glass by repeated recycle of the off-gas condensate into the LAW melter. Other radionuclides that are also expected to be in appreciable concentration in the LAW Off-Gas Condensate are 129 I, 90 Sr, 137 Cs, and {sup 241}Am. This report discusses results of preliminary radionuclide decontamination testing of the simulant. Testing examined use of Monosodium Titanate (MST) to remove 90 Sr and actinides, inorganic reducing agents for 99 Tc, and zeolites for 137 Cs. Test results indicate that excellent removal of 99 Tc was achieved using Sn(II)Cl 2 as a reductant, coupled with sorption onto hydroxyapatite, even in the presence of air and at room temperature. This process was very effective at neutral pH, with a Decontamination Factor (DF) >577 in two hours. It was less effective at alkaline pH. Conversely, removal of the cesium was more effective at alkaline pH, with a DF of 17.9. As anticipated, ammonium ion probably interfered with the Ionsiv®a IE-95 zeolite uptake of 137 Cs. Although this DF of 137 Cs was moderate, additional testing is expected to identify more effective conditions. Similarly, Monosodium Titanate (MST) was more effective at alkaline pH at removing Sr, Pu, and U, with a DF of 319, 11.6, and 10.5, respectively, within 24 hours. Actually, the Ionsiv® IE-95, which was targeting removal of Cs, was also moderately effective for Sr, and highly effective for Pu and U at alkaline pH. The only deleterious effect observed was that the chromium co-precipitates with the {sup 99}Tc during the SnCl 2 reduction. This effect was anticipated, and would have to be considered when managing disposition paths of this stream. Results of this separation testing indicate that sorption/precipitation was a viable concept and has the potential to decontaminate the stream. All radionuclides were at least partially removed by one or more of the materials tested. Based on the results, a possible treatment scenario could involve the use of a reductive precipitation agent (SnCl 2 ) and sorbent at neutral pH to remove the Tc, followed by pH adjustment and the addition of zeolite (Ionsiv® IE-95) to remove the Cs, Sr, and actinides. Addition of MST to remove Sr and actinides may not be needed. Since this was an initial phase of testing, additional tasks to improve separation methods were expected to be identified. Primarily, further testing is needed to identify the conditions for the decontamination process. Once these conditions are established, follow-on tasks likely include evaluation and testing of applicable solid-liquid separation technologies, slurry rheology measurements, composition variability testing and evaluations, corrosion and erosion testing, slurry storage and immobilization investigations, and decontaminated LAW Off-Gas Condensate evaporation and solidification.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

LABORATORY OPTIMIZATION TESTS OF TECHNETIUM DECONTAMINATION OF HANFORD WASTE TREATMENT PLANT LOW ACTIVITY WASTE OFF-GAS CONDENSATE SIMULANT

The Hanford Waste Treatment and Immobilization Plant (WTP) Low Activity Waste (LAW) vitrification facility will generate an aqueous condensate recycle stream (LAW Off-Gas Condensate) from the off-gas system. The baseline plan for disposition of this stream is to send it to the WTP Pretreatment Facility, where it will be blended with LAW, concentrated by evaporation and recycled to the LAW vitrification facility again. Alternate disposition of this stream would eliminate recycling of problematic components, and would enable de-coupled operation of the LAW melter and the Pretreatment Facilities. Eliminating this stream from recycling within WTP would also decrease the LAW vitrification mission duration and quantity of glass waste. This LAW Off-Gas Condensate stream contains components that are volatile at melter temperatures and are problematic for the glass waste form. Because this stream recycles within WTP, these components accumulate in the Condensate stream, exacerbating their impact on the number of LAW glass containers that must be produced. Approximately 32% of the sodium in Supplemental LAW comes from glass formers used to make the extra glass to dilute the halides to acceptable concentrations in the LAW glass, and diverting the stream reduces the halides in the recycled Condensate and is a key outcome of this work. Additionally, under possible scenarios where the LAW vitrification facility commences operation prior to the WTP Pretreatment facility, identifying a disposition path becomes vitally important. This task examines the potential treatment of this stream to remove radionuclides and subsequently disposition the decontaminated stream elsewhere, such as the Effluent Treatment Facility (ETF), for example. The treatment process envisioned is very similar to that used for the Actinide Removal Process (ARP) that has been operating for years at the Savannah River Site (SRS), and focuses on using mature radionuclide removal technologies that are also compatible with longterm tank storage and immobilization methods. For this new application, testing is needed to demonstrate acceptable treatment sorbents and precipitating agents and measure decontamination factors for additional radionuclides in this unique waste stream. The origin of this LAW Off-Gas Condensate stream will be the liquids from the Submerged Bed Scrubber (SBS) and the Wet Electrostatic Precipitator (WESP) from the LAW melter off-gas system. The stream is expected to be a dilute salt solution with near neutral pH, and will likely contain some insoluble solids from melter carryover. The soluble components are expected to be mostly sodium and ammonium salts of nitrate, chloride, and fluoride. This stream has not been generated yet and will not be available until the WTP begins operation, but a simulant has been produced based on models, calculations, and comparison with pilot-scale tests. One of the radionuclides that is volatile and expected to be in greatest abundance in this LAW Off-Gas Condensate stream is Technetium-99 ({sup 99}Tc). Technetium will not be removed from the aqueous waste in the Hanford WTP, and will primarily end up immobilized in the LAW glass by repeated recycle of the off-gas condensate into the LAW melter. Other radionuclides that are low but are also expected to be in measurable concentration in the LAW Off-Gas Condensate are {sup 129}I, {sup 90}Sr, {sup 137}Cs, {sup 241}Pu, and {sup 241}Am. These are present due to their partial volatility and some entrainment in the off-gas system. This report discusses results of optimized {sup 99}Tc decontamination testing of the simulant. Testing examined use of inorganic reducing agents for {sup 99}Tc. Testing focused on minimizing the quantity of sorbents/reactants added, and minimizing mixing time to reach the decontamination targets in this simulant formulation. Stannous chloride and ferrous sulfate were tested as reducing agents to determine the minimum needed to convert soluble pertechnetate to the insoluble technetium dioxide. The reducing agents were tried with and without sorbents. The sorbents, hydroxyapatite and sodium oxalate, were expected to sorb the precipitated technetium dioxide and facilitate removal. The Phase 1 tests examined a broad range of conditions and used the initial baseline simulant. The Phase 2 tests narrowed the conditions based on Phase 1 results, and used a slightly modified simulant. Test results indicate that excellent removal of {sup 99}Tc was achieved using SnCl{sub 2} as a reductant, and was effective with or without sorption onto hydroxyapatite. This reaction worked even in the presence of air (which could oxidize the stannous ion) and at room temperature. This process was very effective at neutral pH, with a Decontamination Factor (DF) >199 in one hour with only 1 g/L of SnCl{sub 2}. Prior work had shown that it was much less effective at alkaline pH. The only deleterious effect observed was that the chromium co-precipitates with the {sup 99}c during the SnCl{sub 2} reduction. This effect was anticipated, and would have to be considered when managing disposition paths of this stream. Reduction using FeSO{sub 4} was not effective at removing {sup 99}Tc, but did remove the Cr. Chromium is present due to partial volatility and entrainment in the off-gas, and is highly oxidizing, so would be expected to react with reducing agents more quickly than pertechnetate. Testing showed that sufficient reducing agent must be added to completely reduce the chromium before the technetium is reduced and removed. Other radionuclides are also present in this off-gas condensate stream. To enable sending this stream to the Hanford ETF, and thereby divert it from the recycle where it impacts the LAW glass volume, several of these also need to be removed. Samples from optimized conditions were also measured for actinide removal in order to examine the effect of the Tc-removal process on the actinides. Plutonium was also removed by the SnCl{sub 2} precipitation process. Results of this separation testing indicate that sorption/precipitation is a viable concept and has the potential to decontaminate the {sup 99}Tc from the stream, allowing it to be diverted away from WTP and thus eliminating the impact of the recycled halides and sulfate on the LAW glass volume. Based on the results, a possible treatment scenario could involve the use of a reductive precipitation agent (SnCl{sub 2}) with or without sorbent at neutral pH to remove the Tc. Although hydroxyapatite was not necessary to effect the {sup 99}Tc removal, it may be beneficial in solid-liquid separations. Other testing will examine removal of the other radionuclides. This testing was the second phase of testing, which aimed at optimizing the process by examining the minimum amount of reductant needed and the minimum reaction time. Although results indicated that SnCl{sub 2} was effective, further work on a pH-adjusted Fe(SO{sub 4}) mixture are needed. Additional tasks are needed to examine removal of the other radionuclides, solid-liquid separation technologies, slurry rheology measurements, composition variability impacts, corrosion and erosion, and slurry storage and immobilization.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

NASA Glenn/AADC Collaboration Optimized Erosion Coatings for Inlet Guide Vanes

There is a need for lightweight, durable materials and structures to reduce the weight of propulsion systems. Polymer matrix composites (PMC's) are promising materials for aerospace applications because of their high strength-to-weight ratio relative to metals. Unfortunately, they are limited to applications where they are not exposed to hightemperature oxidizing atmospheres and/or particulates from ingested air. This is because oxidation and erosion occur on the surface, leading to weight loss, nodulation, and/or cracking on the surface, and a consequent decline of mechanical properties over time. Although prior research has shown that oxidation can be slowed when metallic or ceramic coatings are applied onto PMC's, there remains a need for erosion-resistant coatings that protect PMC's from high-velocity particulates in the engine flow path. These erosionresistant coatings could extend the life of polymer composites. Polymer composites are heavily damaged without an erosion-resistant coating because they are not as hard as metallic engine structures. The effectiveness and life of the coatings depends on their inherent properties as well as on the interaction between the coating and the PMC. Since polymers, in general, have high thermal expansion coefficients in comparison to metals and ceramics, failure of the coatings often occurs at this interface. The objective of this research is to develop strategies to improve this interface and tailor overlays for erosion resistance. The bondcoat, which was developed at the NASA Glenn Research Center, is composed of zinc blended with polyimides to improve the compatibility between the PMC and the overlay material. Initial coating trials at AADC produced vanes that had poor bonding between the overlay and bondcoats. Subsequently, Glenn successfully demonstrated that high-quality plasma-sprayed erosion coating systems could be applied to these guide vanes. Inlet guide vanes from AE 3007 engines fiber composites were coated using a coating system composed of a bondcoat and a hard topcoat. Optimization of the plasma spray process has led to plans for future erosion testing in gas turbine engine environments.

Sutter, James K.↗

International Government Collaboration in ISD (In Situ Decommissioning/In Situ Disposal) - 19261

In situ decommissioning (ISD) is considered by IAEA as the permanent entombment of a legacy facility in 'a structurally long lived material' (e.g. concrete) and is considered a solution only under 'exceptional circumstances' (e.g. following a severe accident). However, this definition of ISD as 'only' entombment is not universally accepted; the approach has been implemented as a decommissioning approach by the US Dept of Energy in the past decade at the Savannah River Site (P and R reactors)2,3, the Hanford site (U Canyon) and at the Idaho site (CP601, CP640 and CP633). The application of ISD outside of the United States has been much less common for large facilities although its use for underground substructures (e.g. discarded pipelines) is commonplace. Proponents of ISD consider it beneficial since it eliminates the need to remove, package and transport contaminated equipment from a nuclear legacy site to a disposal facility and it maximizes the use of an existing nuclear site footprint by consolidating equipment in one place. ISD is considered to offer major safety benefits to both workers and the public, as well as major cost and schedule benefits to Government. Opponents of the approach cite the fact that, following ISD, the decommissioned facility has effectively become a long-term waste disposal site and that regulations pertaining to long term waste disposal have been circumvented. Given the increasing pressure on environmental cleanup budgets and schedules around the world, countries such as the United Kingdom, Canada and Japan are considering ISD in its various forms as a potential path forward for decommissioning certain facilities in lieu of the more traditional approaches of either deferred decommissioning or immediate decontamination/demolition. To address this emerging area of decommissioning, a Governmental Technical Information Exchange meeting was held in December 2017 at the DOE Savannah River Site in Aiken, SC, to bring together responsible parties from the US Dept of Energy (DOE), Atomic Energy of Canada Ltd (AECL), the UK Nuclear Decommissioning Authority (NDA) and the Japanese Atomic Energy Agency (JAEA) and those countries' respective regulatory agencies to share information about respective 'best practices' and challenges with ISD. Representatives from organizations such as IAEA and US Nuclear Regulatory Commission (US NRC) also participated to discuss their organizations' perspectives and position on ISD. Following the meeting, a series of Working Groups were established which have continued the dialogue in three key areas 5; - ISD-Defined: Identify and share case-specific ISD solutions which allows for the full spectrum of needs and which demonstrate that 'entombment' is not the only definition of 'ISD'. - Regulatory - Share and discuss regulatory concerns and challenges with ISD; - Benchmarking - Share information to support informed and transparent decision-making in ISD. This paper discusses the plans for ISD in some of the countries involved in the December meeting and provides an update on the topics being discussed, and progress being made, by the Working Groups that were formed at the meeting. (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

SU-E-T-98: Dependence of Radiotherapy Couch Transmission Factors On Field Size and Couch-Isocenter Distance

Purpose: The dosimetric effect of the treatment couch is non-negligible in today's radiotherapy treatment. To accurately include couch in dose calculation, we investigated the dependence of couch transmission factors on field size and couch-isocenter distance. Methods: Couch transmission factors for Varian Exact Couch were determined by taking the ratios of ionization of a posterior-anterior beam with and without the couch in the beam path. Measurements were performed at the isocenter using a PTW cylindrical ionization chamber (Model 31030) with an Aluminum buildup cap of 1.1 cm thick for the 6 MV photon beam. Ionization readings for beam sizes ranging from 2 × 2 cm2 to 40 × 40 cm2 were taken. Transmission factors for couch-isocenter distances ranging from 3 cm to 20 cm were also investigated. Results: The couch transmission factors increased with the field size approximately in an exponential manner. For the field sizes that we tested, the transmission factor ranged from 0.976 to 0.992 for couch-isocenter distance of 3 cm. The transmission factor was also monotonically dependent on couch-isocenter separation distance, but in a lighter magnitude. For the tested couch heights, the transmission factor ranged from 0.974 – 0.972 for 2 × 2 cm2 field size and 0.992 – 0.986 for 40 × 40 cm2 field size. The dependence on couch-isocenter distance is stronger for larger field size. Conclusions: The transmission factor of a radiotherapy treatment couch increases with field size of the radiation beam and its distance from the isocenter. Such characterization of the couch transmission factor helps improve the accuracy of couch modeling for radiotherapy treatment planning.

60 APPLIED LIFE SCIENCES↗

Laboratory Evaporation Testing Of Hanford Waste Treatment Plant Low Activity Waste Off-Gas Condensate Simulant

The Hanford Waste Treatment and Immobilization Plant (WTP) Low Activity Waste (LAW) vitrification facility will generate an aqueous condensate recycle stream, LAW Off-Gas Condensate, from the off-gas system. The baseline plan for disposition of this stream is to send it to the WTP Pretreatment Facility, where it will be blended with LAW, concentrated by evaporation and recycled to the LAW vitrification facility again. Alternate disposition of this stream would eliminate recycling of problematic components, and would enable de-coupled operation of the LAW melter and the Pretreatment Facilities. Eliminating this stream from recycling within WTP would also decrease the LAW vitrification mission duration and quantity of canistered glass waste forms. This LAW Off-Gas Condensate stream contains components that are volatile at melter temperatures and are problematic for the glass waste form. Because this stream recycles within WTP, these components accumulate in the Condensate stream, exacerbating their impact on the number of LAW glass containers that must be produced. Approximately 32% of the sodium in Supplemental LAW comes from glass formers used to make the extra glass to dilute the halides to be within acceptable concentration ranges in the LAW glass. Diverting the stream reduces the halides in the recycled Condensate and is a key outcome of this work. Additionally, under possible scenarios where the LAW vitrification facility commences operation prior to the WTP Pretreatment facility, identifying a disposition path becomes vitally important. This task examines the impact of potential future disposition of this stream in the Hanford tank farms, and investigates auxiliary evaporation to enable another disposition path. Unless an auxiliary evaporator is used, returning the stream to the tank farms would require evaporation in the 242-A evaporator. This stream is expected to be unusual because it will be very high in corrosive species that are volatile in the melter (chloride, fluoride, sulfur), will have high ammonia, and will contain carryover particulates of glass-former chemicals. These species have potential to cause corrosion of tanks and equipment, precipitation of solids, release of ammonia gas vapors, and scale in the tank farm evaporator. Routing this stream to the tank farms does not permanently divert it from recycling into the WTP, only temporarily stores it prior to reprocessing. Testing is normally performed to demonstrate acceptable conditions and limits for these compounds in wastes sent to the tank farms. The primary parameter of this phase of the test program was measuring the formation of solids during evaporation in order to assess the compatibility of the stream with the evaporator and transfer and storage equipment. The origin of this LAW Off-Gas Condensate stream will be the liquids from the Submerged Bed Scrubber (SBS) and the Wet Electrostatic Precipitator (WESP) from the LAW facility melter offgas system. The stream is expected to be a dilute salt solution with near neutral pH, and will likely contain some insoluble solids from melter carryover. The soluble components are expected to be mostly sodium and ammonium salts of nitrate, chloride, and fluoride. This stream has not been generated yet, and, thus, the composition will not be available until the WTP begins operation, but a simulant has been produced based on models, calculations, and comparison with pilot-scale tests. This report discusses results of evaporation testing of the simulant. Two conditions were tested, one with the simulant at near neutral pH, and a second at alkaline pH. The neutral pH test is comparable to the conditions in the Hanford Effluent Treatment Facility (ETF) evaporator, although that evaporator operates at near atmospheric pressure and tests were done under vacuum. For the alkaline test, the target pH was based on the tank farm corrosion control program requirements, and the test protocol and equipment was comparable to that used for routine evaluation of feed compatibility studies for the 242-A evaporator. One of the radionuclides that is volatile in the melter and expected to be in high concentration in this LAW Off-Gas Condensate stream is Technetium-99 (99Tc). Technetium will not be removed from the aqueous waste in the Hanford WTP, and will primarily end up immobilized in the LAW glass by repeated recycle of the off-gas condensate into the LAW melter. Other radionuclides that are also expected to be in appreciable concentrations in the LAW Off-Gas Condensate are 129I, 90Sr, 137Cs, and 241Am. The concentrations of these radionuclides in this stream will be much lower than in the LAW, but they will still be higher than limits for some of the other disposition pathways currently available. At this time, these scoping tests did not evaluate the partitioning of the radionuclides to the evaporator condensate, since ample data are available separately from other experience in the DOE complex. Results from the evaporation testing show that the neutral SBS simulant first forms turbidity at ~7.5X concentration, while the alkaline-adjusted simulant became turbid at ~3X concentration. The major solid in both cases was Kogarkoite, Na3FSO4. Sodium and lithium fluorides were also detected. Minimal solids were formed in the evaporator bottoms until a substantial fraction of liquid was removed, indicating that evaporation could minimize storage volume issues. Achievable concentration factors without significant insoluble solids were 17X at alkaline pH, and 23X at neutral pH. In both runs, significant ammonia carried over and was captured in the condenser with the water condensate. Results also indicate that with low insoluble solids formation in the initial testing at neutral pH, the use of Reverse Osmosis is a potential alternate method for concentrating the solution, although an evaluation is needed to identify equipment that can tolerate insoluble solids. Most of the ammonia remains in the evaporator bottoms during the neutral pH evaporation, but partitions to the condensate during alkaline evaporation. Disposition of both streams needs to consider the management of ammonia vapor and its release. Since this is an initial phase of testing, additional tasks related to evaporation methods are expected to be identified for development. These tasks likely include evaluation and testing of composition variability testing and evaluations, corrosion and erosion testing, slurry storage and immobilization investigations, and evaporator condensate disposition.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Effects Influencing Plutonium-Absorber Interactions and Distributions in Routine and Upset Waste Treatment Plant Operations

This report is the third in a series of analyses written in support of a plan to revise the Hanford Waste Treatment and Immobilization Plant (WTP) Preliminary Criticality Safety Evaluation Report (CSER) that is being implemented at the request of the U.S. Department of Energy (DOE) Criticality Safety Group. A report on the chemical disposition of plutonium in Hanford tank wastes was prepared as Phase 1 of this plan (Delegard and Jones 2015). Phase 2 is the provision of a chemistry report to describe the potential impacts on criticality safety of waste processing operations within the WTP (Freer 2014). In accordance with the request from the Environmental and Nuclear Safety Department of the WTP (Miles and Losey 2012), the Phase 2 report assessed the potential for WTP process conditions within and outside the range of normal control parameters to change the ratio of fissile material to neutron-absorbing material in the waste as it is processed with an eye towards potential implications for criticality safety. The Phase 2 study also considered the implications should WTP processes take place within the credible range of chemistry upset conditions. In the present Phase 3 report, the 28 phenomena described in the Phase 2 report were considered with respect to the disposition of plutonium and various absorber elements. The phenomena identified in the Phase 2 report are evaluated in light of the Phase 1 report and other resources to determine the impacts these phenomena might have to alter the plutonium/absorber dispositions and ratios. The outcomes of the Phase 3 evaluations then can be used to inform subsequent engineering decisions and provide reasonable paths forward to mitigate or overcome real or potential criticality concern in plant operations.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Evaluation of the Impact of Thin Pours on Saltstone Properties

The proposed Saltstone Disposal Unit 6 (SDU6) is a larger structure than the SDU4 cells and larger than the disposal units (SDU2, SDU3, and SDU5) currently in use or under construction. The additional capacity provided by SDU6 is desired to reduce life cycle costs and support site accelerated closure goals. The larger size of the planned SDU6 could result in saltstone being placed in thinner lifts as the unit is filled. This study was performed to determine whether thinner layers of saltstone negatively impact the performance of the waste form. A larger number of cold joints could potentially result in increased drying, salt deposition, and surface oxidation. A matrix of samples was prepared to simulate thin pours ranging from 0.5 to 6 inches thick. Each sample was cured for at least 28 days prior to further characterization. Leachability results showed that there is no obvious impact of the number of grout layers on the Leachability Index values for Na and NO 3 . The concentrations of Cr, NO 2 , and C 2 O 4 were below detection limits for all of the leachates. No attempt was made to evaluate the oxidation of these samples since no measureable Cr was leached, although this would appear to indicate that Cr in the samples remained reduced for cold joints with surfaces exposed for approximately four days. The results of hydraulic conductivity measurements showed that the number of cold joints in the samples did not have a significant impact on the measured values for the vertical lift orientation (i.e., when the flow path is perpendicular to the cold joints). For the horizontal lift orientation (i.e., when the flow path is parallel to the cold joints), the number of cold joints in the samples also did not appear to have a significant impact on hydraulic conductivity. The measured hydraulic conductivity was faster when the flow path was parallel to the cold joints as compared to when the flow path was perpendicular to the cold joints. Percolation testing showed increased flow when the number of cold joints was increased. Compressive strength testing showed that the maximum load at the onset of cracking was reduced by approximately 26% for those samples that contained cold joints as compared to the monolithic samples. The number of cold joints in the sample had no significant impact on the maximum load prior to cracking. The porosity of the samples was not influenced by cold joints. This result was expected as the porosity is a material property affected by the properties of the components (premix and salt solution) and the water to premix ratio. Overall, the only obvious impact of cold joints in the samples was to significantly increase hydraulic conductivity in the direction parallel to the cold joints. An increasing number of cold joints (thin layers) in the simulated saltstone samples did not exacerbate this effect, nor did it have a negative impact on the Leachability Indices or porosity for surfaces exposed for approximately four days. The presence of a cold joint reduced the compressive strength of the material, although this impact was seen regardless of the number of cold joints in the sample.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Radiative Transfer Through Clouds and Its Applications in Support of the Ice, Cloud, and Land Elevation Satellite-2 (ICESat-2) Mission

The Greenland and Antarctic ice sheets, which contain enough ice to raise sea level by about 7 and 60 m, respectively, are losing mass at an increasing rate. To acquire continuous information of the cryosphere, after the Ice, Cloud, and land Elevation Satellite (ICESat) (2003-2010), NASA is actively planning for the ICESat-2 mission. Both ICESat and ICESat-2 are space-borne lidar altimetry systems. The systems measure the time of flight of the arriving photons that are reflected by the surface to deduce the elevation of the underlying terrain. As one of NASA's top priority missions, ICESat-2 is scheduled to launch in 2016. One of the major science goals of ICESat-2 is to quantify the ice sheet mass balance to determine its contributions to the sea level change and its impacts on ocean circulation (Abdalati et al. 2010). Compared to ICESat, which operates at 40 Hz and records the reflected laser energy as a waveform, the significantly improved ICESat-2 lidar employs a 532 nm micro-pulse photon counting system that operates at a high frequency of 10kHz with single photon detectability (Yang et al. 2012). To achieve its science goals, ICESat-2 requires the ability of detecting the elevation change with an accuracy of 0.2 cm/year over the entire ice sheet. Since every photon emitted by the lidar system will travel through the atmosphere, clouds can certainly affect the flight time of the arriving photons. Forward scattering by cloud particles increases the photon path length, thus resulting in biases in ice sheet elevation measurements known as atmospheric path delay (Duta et al. 2001, Yang et al. 2010, 2011). To ensure the accuracy of ICESat-2 surface elevation measurements, it is critical to understand how clouds would affect the travel time of arriving photons. In this talk, we will first present a framework that simulates the behavior of a space-borne 532 mn micro-pulse photon counting lidar in cloudy and clear atmospheres. To investigate the process of laser propagation through clouds, a 3-D Monte Carlo radiative transfer model is used to simulate the photon path distribution and the Poisson distribution is adopted for the number of photon returns. Since the photon counting system only registers the time of the first arriving photon within the detector "dead time", the retrieved average surface elevation tends to bias towards higher values. This is known as the first photon bias. With the scenarios simulated here, the first photon bias for clear sky is about 6.5 cm. Clouds affect surface altimetry in two ways: (1) cloud attenuation lowers the average number of arriving photons and hence reduces the first photon bias; (2) cloud forward scattering increases the photon path length and makes the surface appear further away from the satellite. Compared to clear sky, the average surface elevation detected by the photon counting system for cloudy sky with optical depth 1.0 is 4.0 to 6.0 cm lower for the simulations conducted. The effect of surface roughness on the accuracy of elevation retrievals will also discussed.

Yang, Yuekui↗

EDL Pathfinder Missions

NASA is developing a long‐term strategy for achieving extended human missions to Mars in support of the policies outlined in the 2010 NASA Authorization Act and National Space Policy. The Authorization Act states that "A long term objective for human exploration of space should be the eventual international exploration of Mars." Echoing this is the National Space Policy, which directs that NASA should, "By 2025, begin crewed missions beyond the moon, including sending humans to an asteroid. By the mid‐2030s, send humans to orbit Mars and return them safely to Earth." Further defining this goal, NASA's 2014 Strategic Plan identifies that "Our long‐term goal is to send humans to Mars. Over the next two decades, we will develop and demonstrate the technologies and capabilities needed to send humans to explore the red planet and safely return them to Earth." Over the past several decades numerous assessments regarding human exploration of Mars have indicated that landing humans on the surface of Mars remains one of the key critical challenges. In 2015 NASA initiated an Agency‐wide assessment of the challenges associated with Entry, Descent, and Landing (EDL) of large payloads necessary for supporting human exploration of Mars. Due to the criticality and long‐lead nature of advancing EDL techniques, it is necessary to determine an appropriate strategy to improve the capability to land large payloads. This paper provides an overview of NASA's 2015 EDL assessment on understanding the key EDL risks with a focus on determining what "must" be tested at Mars. This process identified the various risks and potential risk mitigation strategies, that is, benefits of flight demonstration at Mars relative to terrestrial test, modeling, and analysis. The goal of the activity was to determine if a subscale demonstrator is necessary, or if NASA should take a direct path to a human‐scale lander. This assessment also provided insight into how EDL advancements align with other Agency Mars lander activities such as the technology portfolio investments and post‐2020 robotic Mars Exploration Program missions.

Drake, Bret G.↗

Voices from Rural Electric Cooperatives: A Call for a DER Integration Playbook for Rural and Agricultural Income & Savings from Renewable Energy (RAISE)

Rural-serving electric utilities (RSEUs)—including electric cooperatives, municipal systems, and small investor-owned utilities—are essential players in the evolving energy landscape. These community-focused entities are increasingly being asked to consider distributed energy resources (DERs) such as rooftop and ground-mounted solar, wind, battery storage, smart water heaters, and demand response programs (NRECA 2025; Lenhart et al. 2020). Yet the path to DER adoption is far from straightforward in the rural context. This report is based on in-depth interviews with managers of rural electric cooperatives across the United States. These conversations offer a grounded, unvarnished look at how DERs are perceived, what barriers exist, and what conditions might enable integration and adoption. While the utilities interviewed vary in geography, size, and DER experience, several clear and common themes emerged across electric cooperatives such that the report recommends the development of a DER Integration Runbook to help utilities assess readiness, define local use cases, engage stakeholders, pilot projects, and iterate, expanding over time.

29 ENERGY PLANNING, POLICY, AND ECONOMY↗